VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 137 filers reported holding VBI VACCINES INC in Q4 2021. The put-call ratio across all filers is 2.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,283 | +9.7% | 20,736 | +41.6% | 0.00% | – |
| Q4 2022 | $5,726 | -61.8% | 14,641 | -30.4% | 0.00% | – |
| Q3 2022 | $15,000 | +66.7% | 21,028 | +92.6% | 0.00% | – |
| Q2 2022 | $9,000 | -83.3% | 10,917 | -66.2% | 0.00% | – |
| Q1 2022 | $54,000 | -22.9% | 32,258 | +7.1% | 0.00% | – |
| Q4 2021 | $70,000 | -38.1% | 30,109 | -17.1% | 0.00% | – |
| Q3 2021 | $113,000 | +15.3% | 36,329 | +24.4% | 0.00% | – |
| Q2 2021 | $98,000 | -13.3% | 29,207 | -19.7% | 0.00% | – |
| Q1 2021 | $113,000 | +1.8% | 36,374 | -9.6% | 0.00% | – |
| Q4 2020 | $111,000 | +58.6% | 40,243 | +64.9% | 0.00% | – |
| Q3 2020 | $70,000 | -15.7% | 24,405 | -8.7% | 0.00% | – |
| Q2 2020 | $83,000 | +388.2% | 26,718 | +51.3% | 0.00% | – |
| Q1 2020 | $17,000 | +21.4% | 17,658 | +73.5% | 0.00% | – |
| Q4 2019 | $14,000 | +100.0% | 10,178 | -27.8% | 0.00% | – |
| Q3 2019 | $7,000 | – | 14,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |